Capacitance-Based Patient Line Blockage Detection
20180001009 · 2018-01-04
Inventors
Cpc classification
A61M1/28
HUMAN NECESSITIES
A61M1/1522
HUMAN NECESSITIES
A61M5/16831
HUMAN NECESSITIES
A61M1/14
HUMAN NECESSITIES
A61M1/1524
HUMAN NECESSITIES
A61M1/3656
HUMAN NECESSITIES
A61M1/155
HUMAN NECESSITIES
A61M1/1561
HUMAN NECESSITIES
A61M2205/52
HUMAN NECESSITIES
International classification
A61M1/14
HUMAN NECESSITIES
A61M1/28
HUMAN NECESSITIES
Abstract
A dialysis machine (e.g., a peritoneal dialysis (PD) machine) can include a pressure sensor mounted at a proximal end of a patient line made of a distensible material that provides PD solution to a patient through a catheter. During treatment, an occlusion can occur at different locations in the patient line and/or the catheter. When an incremental volume of additional solution is provided to the patient line while the occlusion is present, a change in pressure results. The change in pressure depends on the dimensions and the distensibility of the non-occluded portion of the patient line. If the change in pressure, the incremental volume, the properties related to the distensibility of the patient line, and some of the dimensions of the patient line are known, the location of the occlusion can be inferred. The occlusion type can be inferred based on the determined location.
Claims
1. A method comprising: measuring a first pressure of fluid in a first portion of a distensible medical tube connected to a medical device, wherein an occlusion is present in the medical tube at a location that defines a boundary between the first portion and a second portion of the medical tube; providing or withdrawing a volume of fluid to or from the first portion of the medical tube; measuring a second pressure of the fluid in the first portion of the medical tube; and determining a length of the first portion of the medical tube based on a difference between the second pressure and the first pressure.
2. The method of claim 1, wherein the medical device comprises a dialysis machine.
3. The method of claim 2, wherein the dialysis machine comprises a peritoneal dialysis (PD) machine.
4. The method of claim 1, wherein the length of the first portion represents the location of the occlusion relative to a proximal end of the medical tube connected to the medical device.
5. The method of claim 1, wherein the first pressure and the second pressure are measured by a pressure sensor at a proximal end of the medical tube connected to the medical device.
6. The method of claim 1, wherein the fluid is at least partially blocked by the occlusion.
7. The method of claim 6, wherein the fluid being at least partially blocked by the occlusion causes an increase or a decrease in pressure in the medical tube.
8. The method of claim 6, wherein the fluid being at least partially blocked by the occlusion causes a distension in the medical tube.
9. The method of claim 1, wherein the medical tube comprises a catheter at a distal end of the medical tube.
10. The method of claim 1, comprising inferring a type of the occlusion based at least in part on a determined location of the occlusion.
11. The method of claim 10, wherein the type of the occlusion comprises one or more of a pinch of the medical tube, a kink in the medical tube, a deposit in the medical tube, and a deposit blocking a hole of a catheter at a distal end of the medical tube.
12. The method of claim 11, wherein the deposit comprises omental fat.
13. The method of claim 1, comprising determining the length of the first portion of the medical tube based on one or more of dimensions of the medical tube, a material composition of the medical tube, and the volume of fluid provided to or withdrawn from the first portion of the medical tube.
14. The method of claim 13, wherein the determination of the length of the first portion of the medical tube is based on a fluidic capacitance of the medical tube.
15. The method of claim 1, comprising measuring a time history of pressures of the fluid in the first portion of the medical tube.
16. The method of claim 1, comprising: measuring two pressures of the fluid in the first portion of the medical tube while the volume of fluid is being provided or withdrawn; and determining the length of the first portion of the medical tube based on a difference between the two pressure measurements and an amount of time elapsed between the two pressure measurements.
17. The method of claim 1, comprising: measuring a third pressure of the fluid in the first portion of the medical tube before the providing or withdrawing of the volume of fluid is abruptly stopped; measuring a plurality of pressures over time of the fluid in the first portion of the medical tube after the providing or withdrawing of the volume of fluid is abruptly stopped; and determining the length of the first portion of the medical tube based on an elapsed time between the third pressure measurement and a fourth pressure measurement of the plurality of pressure measurements over time.
18. A method comprising: providing or withdrawing a volume of fluid to or from a first portion of a distensible medical tube connected to a medical device, wherein an occlusion is present in the medical tube at a location that defines a boundary between the first portion and a second portion of the medical tube; measuring two pressures of the fluid in the first portion of the medical tube while the volume of fluid is being provided or withdrawn; and determining a length of the first portion of the medical tube based on a difference between the two pressure measurements and an amount of time elapsed between the two pressure measurements.
19. The method of claim 18, wherein the medical device comprises a dialysis machine.
20. The method of claim 19, wherein the dialysis machine comprises a PD machine.
21. The method of claim 18, wherein the length of the first portion represents the location of the occlusion relative to a proximal end of the medical tube connected to the medical device.
22. The method of claim 18, wherein the two pressures are measured by a pressure sensor at a proximal end of the medical tube connected to the medical device.
23. The method of claim 18, wherein the fluid is at least partially blocked by the occlusion.
24. The method of claim 23, wherein the fluid being at least partially blocked by the occlusion causes an increase or a decrease in pressure in the medical tube.
25. The method of claim 23, wherein the fluid being at least partially blocked by the occlusion causes a distension in the medical tube.
26. The method of claim 18, wherein the medical tube comprises a catheter at a distal end of the medical tube.
27. The method of claim 18, comprising inferring a type of the occlusion based at least in part on a determined location of the occlusion.
28. The method of claim 27, wherein the type of the occlusion comprises one or more of a pinch of the medical tube, a kink in the medical tube, a deposit in the medical tube, and a deposit blocking a hole of a catheter in the catheter region at a distal end of the medical tube.
29. The method of claim 18, comprising determining the length of the first portion of the medical tube based on one or more of dimensions of the medical tube, a material composition of the medical tube, and the volume of fluid provided to or withdrawn from the first portion of the medical tube.
30. The method of claim 29, wherein the determination of the length of the first portion of the medical tube is based on a fluidic capacitance of the medical tube.
31. The method of claim 18, wherein the difference between the two pressure measurements and the amount of time elapsed between the two pressure measurements comprises a slope of a portion of a pressure waveform, the portion of the pressure waveform corresponding to times during which the volume of fluid is being provided or withdrawn.
32. A medical device comprising: a distensible medical tube having a proximal end connected to a port of the medical device, wherein an occlusion is present in the medical tube at a location that defines a boundary between a first portion of the medical tube and a second portion of the medical tube; a pressure sensor at the proximal end of the medical tube, the pressure sensor configured for measuring a first pressure of fluid in the first portion of the medical tube; one or more pumps configured for providing or withdrawing a volume of fluid to or from the first portion of the medical tube, wherein the pressure sensor is configured for measuring a second pressure of the fluid in the first portion of the medical tube; and a processor configured for determining a length of the first portion of the medical tube based on a difference between the second pressure and the first pressure.
33. The medical device of claim 32, wherein the medical device comprises a dialysis machine.
34. The medical device of claim 33, wherein the dialysis machine comprises a PD machine.
35. The medical device of claim 32, wherein the length of the first portion represents the location of the occlusion relative to the proximal end of the medical tube.
36. The medical device of claim 32, wherein the medical tube comprises a catheter at a distal end of the medical tube.
37. The medical device of claim 32, wherein the processor is configured to infer a type of the occlusion based at least in part on a determined location of the occlusion.
38. The medical device of claim 32, wherein the processor is configured to determine the length of the first portion of the medical tube based on one or more of dimensions of the medical tube, a material composition of the medical tube, a fluid capacitance of the medical tube, and the volume of fluid provided to or withdrawn from the first portion of the medical tube.
39. A medical device comprising: a distensible medical tube having a proximal end connected to a port of the medical device, wherein an occlusion is present in the medical tube at a location that defines a boundary between a first portion of the medical tube and a second portion of the medical tube; one or more pumps configured for providing or withdrawing a volume of fluid to or from the first portion of the medical tube; a pressure sensor at the proximal end of the medical tube, the pressure sensor configured for measuring two pressures of the fluid in the first portion of the medical tube while the volume of fluid is being provided or withdrawn; and a processor configured for determining a length of the first portion of the medical tube based on a difference between the two pressure measurements and an amount of time elapsed between the two pressure measurements.
40. The medical device of claim 39, wherein the medical device comprises a dialysis machine.
41. The medical device of claim 40, wherein the dialysis machine comprises a PD machine.
42. The medical device of claim 39, wherein the length of the first portion represents the location of the occlusion relative to the proximal end of the medical tube.
43. The medical device of claim 39, wherein the medical tube comprises a catheter at a distal end of the medical tube.
44. The medical device of claim 39, wherein the processor is configured to infer a type of the occlusion based at least in part on a determined location of the occlusion.
45. The medical device of claim 39, wherein the processor is configured to determine the length of the first portion of the medical tube based on one or more of dimensions of the medical tube, a material composition of the medical tube, a fluid capacitance of the medical tube, and the volume of fluid provided to or withdrawn from the first portion of the medical tube.
46. The medical device of claim 39, wherein the difference between the two pressure measurements and the amount of time elapsed between the two pressure measurements comprises a slope of a portion of a pressure waveform, the portion of the pressure waveform corresponding to times during which the volume of fluid is being provided or withdrawn.
Description
DESCRIPTION OF DRAWINGS
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
[0123]
[0124]
[0125]
[0126]
[0127]
[0128]
[0129]
[0130]
[0131]
[0132]
[0133]
[0134]
[0135]
[0136]
[0137]
[0138] Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION
[0139] A dialysis machine (e.g., a peritoneal dialysis (PD) machine) can include a pressure sensor mounted at a proximal end of a patient line made of a distensible material (e.g., an elastomeric patient line) that provides PD solution to a patient through a catheter. During treatment, an occlusion can occur at different locations in the patient line and/or the catheter. When an incremental volume ΔV.sub.f of additional solution is provided to the patient line while the occlusion is present, a change in pressure ΔP (e.g., a pressure rise) results. The change in pressure ΔP depends on the dimensions and the distensibility of the non-occluded portion of the patient line. If the change in pressure ΔP, the incremental volume ΔV.sub.f, the properties related to the distensibility of the patient line, and some of the dimensions of the patient line are known, the location of the occlusion (e.g., the distance x between the patient line port and the occlusion) can be inferred. Because some types of occlusions typically occur in certain parts of the patient line, the occlusion type can be inferred based on the determined location.
[0140] In some implementations, the location of the occlusion can be determined by measuring a change in pressure measurements over time while an additional volume of solution is provided to the patient line. In some implementations, the location of the occlusion can be determined by measuring an amount of time required for pressure measurements to decay below a predetermined threshold after an additional volume of solution is provided to the patient line.
[0141] In some implementations, the patient line may include a fluid capacitive element that is located between a patient line region and a catheter region of the patient line. The fluidic capacitive element may have a distensibility that is substantially greater than that of the patient line itself. Accordingly, occlusions that occur between the dialysis machine and the fluid capacitive element do not cause the pressure sensor to experience the effects of the fluid capacitive element, and occlusions that occur between the fluid capacitive element and the tip of the catheter do cause the pressure sensor to experience the effects of the fluid capacitive element. That is, the fluid capacitive element may be positioned strategically such that the generated information can localize the occlusion to a region of particular interest. For example, by analyzing characteristics of a plurality of pressure measurements over time, including steady-state measurements and measurements of a transient (e.g., fluctuating) component of the measured pressures over time, a determination can be made as to whether the occlusion is present in the patient line region (e.g., outside of the patient) or the catheter region (e.g., inside the patient).
[0142]
[0143] Dialysate bags 122 are suspended from fingers on the sides of the cart 104, and a heater bag 124 is positioned in the heater tray 116. The dialysate bags 122 and the heater bag 124 are connected to the cassette 112 via dialysate bag lines 126 and a heater bag line 128, respectively. The dialysate bag lines 126 can be used to pass dialysate from dialysate bags 122 to the cassette 112 during use, and the heater bag line 128 can be used to pass dialysate back and forth between the cassette 112 and the heater bag 124 during use. In addition, a patient line 130 and a drain line 132 are connected to the cassette 112. The patient line 130 can be connected to a patient's abdomen via a catheter (e.g., the catheter 1002 of
[0144] The PD machine 102 also includes a control unit 139 (e.g., a processor). The control unit 139 can receive signals from and transmit signals to the touch screen display 118, the control panel 120, and the various other components of the PD system 100. The control unit 139 can control the operating parameters of the PD machine 102. In some implementations, the control unit 139 is an MPC823 PowerPC device manufactured by Motorola, Inc.
[0145]
[0146] The PD system 100 also includes encoders (e.g., optical encoders) that measure the rotational movement of the lead screws. The axial positions of the pistons 133A, 133B can be determined based on the rotational movement of the lead screws, as determined by the encoders. Thus, the measurements of the encoders can be used to accurately position the piston heads 134A, 134B of the pistons 133A, 133B.
[0147] As discussed below, when the cassette 112 (shown in
[0148] As shown in
[0149] The pressure sensors 151A, 151B can be any sensors that are capable of measuring the fluid pressure in the sensing chambers 163A, 163B. In some implementations, the pressure sensors are solid state silicon diaphragm infusion pump force/pressure transducers. One example of such a sensor is the Model 1865 force/pressure transducer manufactured by Sensym Foxboro ICT. In some implementations, the force/pressure transducer is modified to provide increased voltage output. The force/pressure transducer can, for example, be modified to produce an output signal of 0 to 5 volts.
[0150] Still referring to
[0151] Still referring to
[0152] The door 108 of the PD machine 102, as shown in
[0153] The control unit (139 of
[0154]
[0155] The annular flanges 164A, 164B of the dome-shaped fastening members 161A, 161B, as shown in
[0156] Referring to
[0157] Still referring to
[0158] The rigidity of the base 156 helps to hold the cassette 112 in place within the cassette compartment 114 of the PD machine 102 and to prevent the base 156 from flexing and deforming in response to forces applied to the projections 154A, 154B by the dome-shaped fastening members 161A, 161B and in response to forces applied to the planar surface of the base 156 by the inflatable members 142. The dome-shaped fastening members 161A, 161B are also sufficiently rigid that they do not deform as a result of usual pressures that occur in the pump chambers 138A, 138B during the fluid pumping process. Thus, the deformation or bulging of the annular portions 149A, 149B of the membrane 140 can be assumed to be the only factor other than the movement of the pistons 133A, 133B that affects the volume of the pump chambers 138A, 138B during the pumping process.
[0159] The base 156 and the dome-shaped fastening members 161A, 161B of the cassette 112 can be formed of any of various relatively rigid materials. In some implementations, these components of the cassette 112 are formed of one or more polymers, such as polypropylene, polyvinyl chloride, polycarbonate, polysulfone, and other medical grade plastic materials. In some implementations, these components can be formed of one or more metals or alloys, such as stainless steel. These components of can alternatively be formed of various different combinations of the above-noted polymers and metals. These components of the cassette 112 can be formed using any of various different techniques, including machining, molding, and casting techniques.
[0160] As noted above, the membrane 140 is attached to the periphery of the base 156 and to the annular flanges 164A, 164B of the dome-shaped fastening members 161A, 161B. The portions of the membrane 140 overlying the remaining portions of the base 156 are typically not attached to the base 156. Rather, these portions of the membrane 140 sit loosely atop the raised ridges 165A, 165B, and 167 extending from the planar surface of the base 156. Any of various attachment techniques, such as adhesive bonding and thermal bonding, can be used to attach the membrane 140 to the periphery of the base 156 and to the dome-shaped fastening members 161A, 161B. The thickness and material(s) of the membrane 140 are selected so that the membrane 140 has sufficient flexibility to flex toward the base 156 in response to the force applied to the membrane 140 by the inflatable members 142. In some implementations, the membrane 140 is about 0.100 micron to about 0.150 micron in thickness. However, various other thicknesses may be sufficient depending on the type of material used to form the membrane 140. Any of various different materials that permit the membrane 140 to deflect in response to movement of the inflatable members 142 without tearing can be used to form the membrane 140. In some implementations, the membrane 140 includes a three-layer laminate. In some implementations, for example, inner and outer layers of the laminate are formed of a compound that is made up of 60 percent Septon® 8004 thermoplastic rubber (i.e., hydrogenated styrenic block copolymer) and 40 percent ethylene, and a middle layer is formed of a compound that is made up of 25 percent Tuftec® H1062 (SEBS: hydrogenated styrenic thermoplastic elastomer), 40 percent Engage® 8003 polyolefin elastomer (ethylene octene copolymer), and 35 percent Septon® 8004 thermoplastic rubber (i.e., hydrogenated styrenic block copolymer). The membrane can alternatively include more or fewer layers and/or can be formed of different materials.
[0161] As shown in
[0162] After positioning the cassette 112 as desired on the cassette interface 110, the door 108 is closed and the inflatable pad within the door 108 is inflated to compress the cassette 112 between the inflatable pad and the cassette interface 110. This compression of the cassette 112 holds the projections 154A, 154B of the cassette 112 in the recesses 152A, 152B of the door 108 and presses the membrane 140 tightly against the raised ridges 167 extending from the planar surface of the rigid base 156 to form the enclosed fluid pathways 158 and dome regions 146 (shown in
[0163]
[0164]
[0165] Referring to
[0166] As the piston 133A continues to advance, the dome-shaped fastening member 161A contacts the inner surface of the portion of the rigid base 156 that forms the recessed region 162A, as shown in
[0167]
[0168] Referring to
[0169]
[0170] After mechanically coupling the piston head 134A of the PD machine 102 to the dome-shaped fastening member 161A of the cassette 112, a priming technique is carried out to remove air from the cassette 112 and from the various lines 126, 128, 130, 132 connected to the cassette 112. To prime the cassette 112 and the lines 126, 128, 130, 132, the piston 133A and inflatable members 142 are typically operated to pump dialysate from the heater bag 124 to the drain and from each of the dialysate bags 122 to the drain. Dialysate is also passed (e.g., by gravity) from the heater bag 124 to the patient line 130 to force any air trapped in the patient line out of a hydrophobic filter positioned at the distal end of the patient line 130.
[0171] After priming is complete, the patient line 130 is connected to the patient and the PD machine 102 is operated to drain any spent dialysate that was left in the patient's peritoneal cavity from a previous treatment. To drain the spent dialysate from the patient's peritoneal cavity, the inflatable members 142 of the PD machine 102 are configured to create an open fluid flow path between the patient line 130 and the port 187A (shown in
[0172] Referring to
[0173] During the patient drain phase of the treatment, the pistons 133A, 133B are typically alternately operated such that the piston 133A is retracted to draw spent dialysate solution into the pump chamber 138A from the patient while the piston 133B is advanced to pump spent dialysate solution from the pump chamber 138B to the drain and vice versa.
[0174] To begin the patient fill phase, the inflatable members 142 are configured to create a clear fluid flow path between the pump chamber 138A and the heater bag line 128, and then the piston 133A is retracted, as shown in
[0175] The warm dialysate is then delivered to the peritoneal cavity of the patient via the patient line 130 by configuring the inflatable members 142 to create a clear fluid flow path between the pump chamber 138A and the patient line 130 and advancing the piston 133A, as shown in
[0176] During the patient fill phase of the treatment, the pistons 133A, 133B are typically alternately operated such that the piston 133A is retracted to draw warm dialysate into the pump chamber 138A from the heater bag 124 while the piston 133B is advanced to pump warm dialysate from the pump chamber 138B to the patient and vice versa. When the desired volume of dialysate has been pumped to the patient, the machine 102 transitions from the patient fill phase to a dwell phase during which the dialysate is allowed to sit within the peritoneal cavity of the patient for a long period of time.
[0177] During the dwell period, toxins cross the peritoneum of the patient into the dialysate from the patient's blood. As the dialysate dwells within the patient, the PD machine 102 prepares fresh dialysate for delivery to the patient in a subsequent cycle. In particular, the PD machine 102 pumps fresh dialysate from one of the four full dialysate bags 122 into the heater bag 124 for heating. To do this, the pump of the PD machine 102 is activated to cause the pistons 133A, 133B to reciprocate and certain inflatable members 142 of the PD machine 102 are inflated to cause the dialysate to be drawn into the fluid pump chambers 138A, 138B of the cassette 112 from the selected dialysate bag 122 via its associated line 126. The dialysate is then pumped from the fluid pump chambers 138A, 138B to the heater bag 124 via the heater bag line 128.
[0178] After the dialysate has dwelled within the patient for the desired period of time, the spent dialysate is pumped from the patient to the drain in the manner described above. The heated dialysate is then pumped from the heater bag 124 to the patient where it dwells for a desired period of time. These steps are repeated with the dialysate from two of the three remaining dialysate bags 122. The dialysate from the last dialysate bag 122 is typically delivered to the patient and left in the patient until the subsequent PD treatment.
[0179] After completion of the PD treatment, the pistons 133A, 133B are retracted in a manner to disconnect the piston heads 134A, 134B from the dome-shaped fastening members 161A, 161B of the cassette. The door 108 of the PD machine 102 is then opened and the cassette 112 is removed from the cassette compartment 114 and discarded.
[0180]
[0181] During a PD treatment cycle, an occlusion can occur at different locations in the conduit. For example, the patient line 130 may become kinked or pinched, holes in the catheter 1002 may become occluded (e.g., with omental fat), or the patient line 130 may develop an internal blockage at some location (e.g., from a deposit of omental fat). The PD machine 102 is configured to adjust its operation in response to an occlusion being detected. For example, the control unit 139 may be configured to adjust one or more operating parameters of the PD machine 102 in an attempt to clear the occlusion and/or to modulate the flow in the patient line to avoid an overpressure condition. In some implementations, the control unit 139 may be configured to provide an alert indicating that an occlusion has been detected. For example, a visual, tactile, and/or audible alert may be directed to the patient (e.g., to wake the patient).
[0182] In order to determine an appropriate response, the PD machine 102 is configured to ascertain the type of occlusion that is present. In some implementations, the type of occlusion can be inferred based on the location of the occlusion in the conduit. For example, if an occlusion is detected in the catheter 1002, the PD machine 102 can infer that holes in the catheter 1002 may be occluded. Similarly, if the occlusion is detected somewhere along the patient line 130, the PD machine 102 can infer that the patient line 130 is kinked or pinched. The PD machine 102 is configured to determine a location of the occlusion relative to the position of the pressure sensor 151A. The particular location of the occlusion can be considered by the PD machine 102 to determine the appropriate response. In the example shown in
[0183] During the treatment, solution is exchanged (e.g., transferred, conveyed, etc.) through the patient line 130. When the PD solution (e.g., the dialysate) being provided to or withdrawn from the patient line 130 encounters an occlusion, the patient line 130 may develop a deformity. For example, in the case of the solution being pumped toward the patient (e.g., solution being injected), the elastic material of the patient line 130 may expand in response to the solution encountering the occlusion, thereby resulting in an increase in volume and pressure within the patient line 130. In the case of the solution being pumped from the patient (e.g., solution being withdrawn), the elastic material of the patient line 130 may contract, thereby resulting in a decrease in volume and pressure within the patient line 130. The distensibility of the non-occluded portion of the conduit (e.g., the portion of the conduit between the patient line port and the occlusion 1008, sometimes referred to as the first portion) can be measured, and the location of the occlusion 1008 can be inferred from the measured value. The occlusion 1008 may define a boundary between the first portion of the conduit and a second portion of the conduit (e.g., the rest of the conduit). It is possible to infer the location of the occlusion 1008 because the distensibility itself arises from, among other things, the length of the non-occluded portion of the conduit 1008 (e.g., the distance x between the patient line port and the occlusion 1008).
[0184] The portion of the conduit between the patient line port and the occlusion 1008 is sometimes referred to as the non-occluded portion of the conduit or the pressurized portion of the conduit. The length of the pressurized portion of the conduit—the distance x between the patient line port and the occlusion 1008—can be determined by approximating the conduit as a thin-walled cylindrical pressure vessel. According to such an approximation, the normal stresses in the wall of the conduit are given according to Equations 1 and 2:
where σ.sub.θis the azimuthal (e.g., “hoop”) stress, σ.sub.z is the longitudinal stress, P.sub.g is the transmural pressure experienced by the conduit (e.g., the gauge pressure of the fluid inside the conduit when the conduit's exterior is exposed to atmospheric pressure), D is the conduit's inner diameter, and w is the conduit's wall thickness. In some implementations (e.g. in implementations in which the conduit has a relatively thick wall), determining the stress state in the conduit may require other consideration in addition to the biaxial stress shown in Equations 1 and 2.
[0185] When a closed volume of tubing of the patient line 130 that is initially filled with a solution has an incremental volume ΔV.sub.f of solution added while the occlusion 1008 is present, a change in pressure ΔP (e.g., a pressure rise) results. The magnitude of the change in pressure ΔP depends on the dimensions and the distensibility of the non-occluded portion of the patient line 130. If the change in pressure ΔP, the incremental volume ΔV.sub.f, the properties related to the distensibility of the patient line 130, and some of the dimensions of the patient line 130 are known, the location of the occlusion 1008 (e.g., the distance x between the patient line port and the occlusion 1008) can be inferred. The incremental volume ΔV.sub.f of added solution as a function of the change in pressure ΔP is given according to Equation 3:
where V.sub.f,i is the initial volume of the non-occluded portion of the patient line 130,
and E.sub.y is the Young's modulus of the material of the patient line 130 (e.g., the Young's modulus of the elastomer). Equation 3 may assume that the Poisson ratio of the elastomer is 0.5, which may be a typical value for a rubber material. Equation 3 is derived from the stress tensor given by Equations 1 and 2, and may assume that the tubing material is isotropic with linear elastic properties.
[0186] Equation 3 implies that for a given incremental volume ΔV.sub.f of injected solution, the resulting rise in pressure ΔP depends upon the initial volume of the pressurized region V.sub.f,i. For conditions where a <<1 (e.g., small strain approximation), ΔP is proportional to
Such a condition is expect to be maintained. In a conservative example (e.g., for soft rubber having E.sub.y≈0.01 gigapascals), a relatively high ΔP of 600 mbar and representative tubing dimensions of D=4 mm and w=1 mm may yield a=0.024. Thus, under the expected conditions, Equation 3 can be approximated by Equation 4:
and Equation 4 can be rearranged to yield Equation 5:
where the fluidic capacitance C.sub.f of the pressurized region of the patient line 130 is given by Equation 6:
[0187] In Equation 6, as in
[0188] To help illustrate the method of measuring the fluidic capacitance C.sub.f of the pressurized region of the patient line 130,
[0189] In reality, the illustrated resistance and capacitance of the patient line 130 are distributed throughout the length of the patient line 130 (e.g., rather than lumped into discrete elements). This fact in addition to other effects (e.g., such as elastic waves and strain-rate-sensitive elastic properties of the patient line 130) may give rise to transient behavior in the pressure in the patient line 130 after injecting the incremental volume of solution ΔV.sub.f. In some examples, measuring the change in pressure ΔP after such transients have subsided may lead to a more accurate measurement of the fluidic capacitance C.sub.f.
[0190] Experiment 1
[0191]
[0192] A relatively small known volume of distilled water (e.g., ΔV.sub.f of approximately 0.33 cubic centimeters) was injected by the syringe pump 1210. The pressure sensor 1206 was configured to measure the pressure in the tube 1230 at the proximal end of the tube 1230 over time. The pressure measurements were made before, during, and after the injection. In some implementations, the pressure measurements occurred at a frequency in the order of hundreds of hertz or thousands of hertz (e.g., 1-2 kHz).
[0193]
[0194] The experiment was then repeated for each of the tested distances x of the occlusion 1208.
[0195] While Experiment 1 has largely been described in terms of a “fill direction” implementation in which an incremental volume ΔV.sub.f of solution is provided to (e.g., dispensed into) the conduit, thereby resulting in a pressure increase, the same principles and equations apply to “drain direction” implementations in which solution is withdrawn from the conduit, thereby resulting in a pressure decrease in the conduit.
[0196] Experiment 2
[0197] Experiment 1 was used to corroborate the validity of Equations 1-6 and to determine a calibration curve for the experimental system 1200 of
[0198] The experiment primarily focused on flow in the drain direction. The choice to focus on flow in the drain direction was made for the following reasons: i) a majority of problematic blockages typically occur in the drain direction; ii) a greater potential for difficulty was predicted in the drain direction due to possible pull-off of cassette film from the pump; and iii) initial tests in the fill direction suggested that the same patterns of pressure versus flow should be obtainable—albeit with different calibration curves that would need to be empirically determined.
[0199]
[0200] The dialysis system 1500 includes the PD machine 102, the PD cassette 112 housed in the PD machine 102, a patient line 1530, and the pressure sensor 151A located at a proximal end of the patient line 1530. The patient line 1530 may be substantially similar to the patient line 130 described above with respect to
[0201] The microcontroller 1536, at the direction of code executed by the computing device 1534, is configured to control the driver modules 1538a, 1538b to cause the driver modules 1538a, 1538b to operate pumps of the PD machine 102 (e.g., the pistons 133A, 133B of
[0202] The ability to detect a partial occlusion (e.g., as compared to detecting a complete occlusion) presents challenges that do not manifest when detecting a complete occlusion. Typically, the less restrictive an occlusion is, the greater is the challenge for sensitivity and specificity of a method for determining its location. A relevant standard for quantifying partial occlusions in the PD machine 102 comes from the Drain Complication and Fill Complication conditions. Drain Complication and Fill Complication conditions occur when there is a flow restriction sufficient to depress the flow below a threshold value for a particular period of time. In a model case of a steady-state flow restriction, the threshold value of restriction that would generate a Drain Complication is one that would require a pressure of approximately −200 mbar (as measured at the pressure sensor 151A) to drive a flow of approximately 30 milliliters per minute.
[0203] The pumps are configured to cause fluid to be pumped through a patient line-catheter conduit that includes the patient line 1530, a catheter 1502, and a port 1504 that connects the patient line 1530 to the catheter 1502. The catheter 1502 may be a Flex Neck Classic catheter. The catheter 1502, the port 1504, and a portion of the patient line 1530 is submerged in a basin of water 1512 (e.g., in place of a patient). The water was held at room temperature (e.g., 20-25° C.). The free surface of the water was kept at the same height (e.g., ±2 centimeters) with respect to the direction of gravity as that of the pressure sensor 151A of the PD cycler 102. An occlusion 1508 was provided in the patient line 1530 at various distances x from the pressure sensor 151A, with the occlusion 1508 defining a boundary between a first portion of the conduit (e.g., the pressured portion) and a second portion of the conduit (e.g., the rest of the conduit). The occlusions 1508 represented partial occlusions.
[0204] The distance x to the occlusions 1508 can be inferred from a measurement of the fluidic capacitance C.sub.f of the pressurized region of a conduit (e.g., the segment of the patient line 1530 between the PD cycler 102 and the occlusion 1508). For a patient line 1530 with tubing of uniform mechanical properties and cross-sectional dimensions (e.g., which is largely true in practice), the fluidic capacitance C.sub.f is related proportionately to the length of tubing comprising the “capacitor.” The so-called capacitor can be “charged” by adding or withdrawing fluid at a fixed rate of flow, in a time interval short compared to the characteristic time of fluidic “leakage” through the partial occlusion. The fluidic capacitance C.sub.f may then be measured by its definition as the slope of distended volume versus pressure. In other words, two or more pressure measurements can be made during the withdrawing or dispensing stroke, the slope of the pressure versus time plot can be determined, and the distance x to the occlusions 1508 can be determined.
[0205] Equation 6 presents the theoretical basis by which the fluidic capacitance C.sub.f is expected to be proportional to the distance x to the occlusion, with the constant of proportionality being a function only of tubing properties and cross-sectional dimensions. Equation 5 can be rearranged to present the differential definition of the fluid capacitance C.sub.f, as shown in Equation 7:
During “charging” of a capacitor by the action of a fixed rate
of fluid injection or removal, the fluidic capacitance C.sub.f can be determined according to Equation 8:
[0206] As was the case in Experiment 1, once the fluidic capacitance C.sub.f of the pressurized region of the patient line 130 is calculated, the distance x to the occlusion can be determined according to Equation 6.
[0207] Experiment 2 included the following general steps, which were performed for occlusions at various different distances: [0208] i. use the pump to add (for Fill Direction testing) or withdraw (for Drain Direction testing) a short burst (e.g., a “short stroke”) of flow at a fixed and known volumetric flow rate; [0209] ii. detect and measure the rate of change of pressure versus time at the pressure sensor 151A; the time interval of data producing the slope estimate may be short compared to the characteristic decay time of the pressure; [0210] iii. calculate the effective fluidic capacitance C.sub.f using Equations 6-8; and [0211] iv. empirically determine a calibration curve between fluidic capacitance C.sub.f and distance x to the occlusion.
[0212] The experiment was performed at various distances x and across a large number of cassettes, with different types, degrees, and locations of flow restriction (e.g., occlusions), in order to investigate the potential sensitivity and specificity of the detection method. Sensitivity and specificity are statistical measures of the performance of the detection method. The sensitivity, also referred to as the true positive rate, measures the proportion of positives that are correctly identified as such. In this context, the sensitivity may correspond to the ability of the system to correctly identify occlusions (e.g., for distances x within a particular range). The specificity, also referred to as the true negative rate, measures the proportion of negatives that are correctly identified as such. In this context, the specificity may correspond to the accuracy of the detection method (e.g., the margin of error of determined distances x).
[0213] a small volume (e.g., approximately 0.33 cubic centimeters) of water was moved through the patient line 1530 in the drain direction by a first pump of the PD machine 102 (e.g., a pump controlled by a first one of the driver modules 1538a) at a fixed rate (e.g., 4.4 cubic centimeters per second). During this stroke, the pressure sensor 151A, which is built into the PD machine 102 and located at the proximal end of the patient line 1530, was used to measure two or more pressure values and detect the slope of pressure versus time for use in Equation 8.
[0214] The pressures were initially measured using both the pressure sensor 151A of the PD machine 102 and a reference pressure transducer 1540 positioned downstream from the pressure sensor 151A. The separate pressure measurements were taken to ensure that the pressure sensor 151A built into the PD machine 102 was capable of achieving the necessary. For example, the pressure sensor 151A is configured to detect the pressure in the patient line 1530 through a membrane of the cassette 112, and various fluidic elements are positioned between the pressure sensor 151A and the proximal end of the patient line 1530. It was considered that these elements may have the potential to diminish and/or distort the accuracy of the pressure measurements. Thus, measurements made by the reference pressure transducer 1540 were used to verify the fidelity of the measurements made by the pressure sensor 151A. A high degree of fidelity was observed, and the reference pressure transducer 1540 was removed to avoid possible artifacts.
[0215]
[0216] The data shown in
[0217] Experiment 3
[0218] Another way to determine the fluidic capacitance C.sub.f of a pressurized region of a conduit is to measure the amount of time required for pressure measurements to decay below a predetermined threshold after fluid is provided to or withdrawn from the conduit in a long, steady-state stroke at a known volumetric flow rate. Like Experiment 2, which studied a technique for determining the fluidic capacitance C.sub.f of a pressurized region of a conduit by measuring a change in pressure during a short dispensing or withdrawing stroke, Experiment 3 was also implemented in an actual dialysis machine (e.g., the PD machine 102 of
[0219] The distance x to the occlusions 1508 can be inferred from a measurement of the fluidic capacitance C.sub.f of a pressurized region of a conduit (e.g., the segment of the patient line 1530 between the PD cycler 102 and the occlusion 1508, sometimes referred to as the first portion). The occlusion 1508 may define a boundary between the first portion of the conduit and a second portion of the conduit (e.g., the rest of the conduit). For a patient line 1530 with tubing of uniform mechanical properties and cross-sectional dimensions (e.g., which is largely true in practice), the fluidic capacitance C.sub.f is related proportionately to the length of tubing comprising the “capacitor.” As described above, the so-called capacitor can be “charged” by adding or withdrawing fluid. The capacitor may then be discharged by cessation of pump flow and thus passively communicating fluid to or from the patient (e.g., the patient's peritoneal cavity). The fluidic capacitance C.sub.f may be inferred from a characteristic time of the pressure decay that occurs during the discharge.
[0220] In general, a characteristic time is an estimate of the order of magnitude of the reaction time scale of a system. In the context of RC circuits and its fluidic analogy to Ohm's Law, the characteristic time is the time required for the capacitor to discharge by 1-1/e (e.g., by approximately 63.2%) from the initial value to the final (e.g., asymptotic) value. Thus, in focusing on the fluidic analogy to RC circuits explored herein, the characteristic time is the time required for the pressure inside the patient line 1530 to change from the initial pressure value to 36.8% of the difference between the initial pressure value and the final pressure value. The characteristic time can be expressed as a time constant, τ. Once the characteristic time constant τ is known, the fluidic capacitance C.sub.f—and in turn, distance x to the occlusion—can be determined.
[0221] Equation 6 presents the theoretical basis by which the fluidic capacitance C.sub.f is expected to be proportional to the distance x to the occlusion, with the constant of proportionality being a function only of tubing properties and cross-sectional dimensions. The relationship between the fluidic capacitance C.sub.f and the characteristic time constant τ is expressed in Equation 9:
t.sub.1 τ=R.sub.fC.sub.f (9)
where R.sub.f is the fluidic resistance representing the partial occlusion itself. The fluidic resistance R.sub.f may be estimated from the fluidic analogy to Ohm's Law, as shown in Equation 10:
t.sub.1R.sub.fΔP/Q (10)
where Q is an imposed volumetric flow rate and ΔP is the change in pressure in response to the imposed volumetric flow rate Q (e.g., the pressure drop across the occlusion).
[0222] Experiment 3 included the following general steps, which were performed for occlusions at various different distances: [0223] i. use the pump to add (for Fill Direction testing) or withdraw (for Drain Direction testing) flow at a fixed and known volumetric flow rate Q, measuring steady-state pressure achieved during this initial flow event; [0224] ii. determine the fluidic resistance R.sub.f using Equation 10; [0225] iii. abruptly stop the flow to allow passive decay of the pressure within the conduit, measuring the pressure versus time during the decay of pressure; [0226] iv. determine the characteristic time constant τ using the pressure measurements; [0227] v. calculate the fluidic capacitance C.sub.f using Equation 9; and [0228] vi. empirically determine a calibration curve between fluidic capacitance C.sub.f and distance x to the occlusion using Equation 6.
[0229] The experiment was performed at various distances x and across a large number of cassettes, with different types, degrees, and locations of flow restriction (e.g., occlusions), in order to investigate the potential sensitivity and specificity of the detection method.
[0230] In this example, fill direction testing will be discussed. A volume of fluid is provided to the patient line 1530 in a long, steady-state stroke at a known volumetric flow rate Q (e.g., sometimes referred to as a “long stroke”). During the pump stroke, an initial steady-state pressure P.sub.1 is reached within the patient line 1530, as measured by the pressure sensor 151A. The initial steady-state pressure P.sub.1 represents the pressure that results from the fixed volumetric flow rate Q and the characteristics of the occlusion 1508. The initial steady-state pressure P.sub.1 is used to calculate the fluidic resistance R.sub.f using Equation 10, where ΔP is the difference between the initial pressure in the patient line 1530 (e.g., before the pump stroke begins) and the initial steady-state pressure P.sub.1 achieved during the pump stroke. In some implementations, the initial steady-state pressure P.sub.1 is measured right before the long stroke is stopped, or when the long stroke is stopped.
[0231] At the end of the pump stroke, the flow is abruptly stopped to allow passive decay of the pressure within the patient line 1530. The pressure sensor 151A makes pressure measurements during the decay of pressure until a final steady-state pressure P.sub.f is achieved (e.g., until the decay is complete and the pressure is not changing anymore). In some implementations, the pump stroke can be abruptly ceased as soon as it is determined that an initial steady-state pressure P.sub.1 has been reached. Once the initial steady-state pressure P.sub.1 and the final steady-state pressure P.sub.f are known, the characteristic time constant τ is determined. The characteristic time constant τ is an elapsed time between the occurrence of the initial steady-state pressure P.sub.1 and the occurrence of one of the plurality of pressure measurements taken during the decay of pressure.
[0232]
[0233] In some implementations, the final steady-state pressure P.sub.f may not be zero.
[0234] In some implementations, a time-averaged pre-stroke zero-flow value may be subtracted from the pressure measurements as an initial step before determining the characteristic time constant τ. In this way, one or both of the starting pressure (e.g., at t=0) and the final steady-state pressure P.sub.f can be adjusted to have a value of 0 mbar, thereby simplifying the characteristic time constant τ determination.
[0235] A similar method can be used for determining the characteristic time constant τ when withdrawing fluid from the patient line 1530. The plot shown in
[0236] Once the characteristic time constant τ is determined, the fluid capacitance C.sub.f is calculated according to Equation 9. The distance x to the occlusion 1508 is then determined according to Equation 6.
[0237] Similar tests can be performed for various other cassette 112/occlusion 1508 configurations at various different distances x for the occlusion 1508. For each test, the calculated fluidic capacitances C.sub.f can be correlated to the various different distances x of the occlusions 1508. The correlated data can be used to create a calibration curve for refining future determinations of occlusion 1508 locations. In this way, errors between calculated distances x according to Equation 6 and the actual distances x of the occlusions 1508 during testing can be considered for calibrating future distance x calculations.
[0238] Experiment 4
[0239] In some implementations, instead of or in addition to determining the exact distance x to the occlusion, the relative location and/or the general location of the occlusion may be determined. For example, characteristics of a plurality of pressure measurements within the conduit can be analyzed to determine whether the occlusion is present in a region of particular interest, such as in a patient line region (e.g., outside the patient) or a catheter region (e.g., inside the patient) of the conduit. The conduit may include a fluid capacitive element that is strategically positioned between the patient line region and the catheter region such that the generated information can localize the occlusion to one region or the other. Based on the determined region of the occlusion, the type of the occlusion (e.g., a pinch in the patient line, an occlusion of the catheter, etc.) can be determined. The determination may be made using existing components (e.g., the pressure sensor 151A) of the PD machine (102 of
[0240]
[0241] Like the patient line 1830, the fluid capacitive element 1810 may also be made of a distensible and/or flexible material that is at least partially distended by operating pressures in the PD machine 102. For example, the fluid capacitive element 1810 may be made of an elastomeric material such as a polymer that develops a swell in response to positive operating pressures in the PD machine 102. In some implementations, the fluid capacitive element 1810 may be part of the patient line 1830 (e.g., an elastomeric segment integrated into the patient line 1830). The fluid capacitive element 1810 may have a distensibility that is substantially greater than that of the patient line 1830 itself For example, the fluid capacitive element 1810 may have the capability to store additional fluid volume with a concomitant increase in local liquid pressure produced by a restoring force. Accordingly, occlusions that occur between the patient line port of the PD machine 102 and the fluid capacitive element 1810 do not cause the pressure sensor 151A to experience the effects of the fluid capacitive element 1810, and occlusions that occur between the fluid capacitive element 1810 and the tip of the catheter 1802 do cause the pressure sensor 151A to experience the effects of the fluid capacitive element 1810.
[0242] During a PD treatment cycle, an occlusion can occur at different locations in the conduit. For example, the patient line 1830 may become kinked or pinched, holes in the catheter 1802 may become occluded (e.g., with omental fat), or the patient line 1830 may develop an internal blockage at some location (e.g., from a deposit of omental fat). The PD machine 102 is configured to adjust its operation in response to an occlusion being detected, as described above with respect to
[0243] To help illustrate the method of analyzing the effect achieved by the addition of the fluid capacitive element 1810 to the conduit,
[0244] The electrical circuit analogies for the fluid mechanic lumped element analysis are shown in Table 1, and the physical and mathematical analogies consistent with the equations in Table 1 are shown in Table 2:
TABLE-US-00001 TABLE 1 Representative Electrical Fluid Expression Circuit Constitutive Constitutive for Fluid Element Law Fluid Effect Law Lumped Parameter Resistor ΔV = IR Viscous pressure loss ΔP = QR.sub.f
TABLE-US-00002 TABLE 2 Electrical Quantity Analogous Fluid Quantity Potential drop or change, ΔV Pressure drop or change, ΔP Charge, q Fluid volume, V.sub.f Current, I Volumetric flow rate, Q Resistance, R Fluidic resistance, R.sub.f Capacitance, C Fluidic capacitance, C.sub.f Inductance, L Fluidic inductance, L.sub.f
[0245] Various assumptions may be made to simplify the mathematical analysis of the equations of Table 1, although such assumptions may not be required in all cases. For example, it may be assumed that the capacitive effects are linear (e.g., pressure increases proportional to fluid volume stored). The fluidic resistance R.sub.f may apply to the case of fully developed laminar flow in a rigid duct of circular cross-section (e.g., constant radius r, length l); for other internal flow situations, other expressions for the fluidic resistance R.sub.f may apply. In the general case (e.g., including turbulent or separating flow), the fluidic resistance R.sub.f itself is a function of the volumetric flow rate Q. The dynamic viscosity is μ. As with the fluidic capacitance C.sub.f, the analysis may be simplified by the linearity resulting from constant values of the fluidic resistance R.sub.f, but such linearity is not required.
[0246] The fluidic capacitance C.sub.f is the change in stored volume ΔV.sub.f of fluid divided by the quantity: change in restoring force ΔF divided by the area A over which the latter acts. The form of an expression for the fluidic capacitance C.sub.f incorporating material properties and dimensions may depend upon the design of the fluid capacitive element 1810 and its mechanism of restoring force (e.g., elastomeric, pneumatic, spring, etc.). The fluidic inductance L.sub.f applies to fluid having a fluid density ρ in a circular duct segment of constant radius r and length l.
[0247] The circuit of
[0248] The object of Experiment 4 is to distinguish an increase in the fluidic resistance of the patient line region of the conduit R.sub.line from an increase in the fluidic resistance of the catheter region of the conduit R.sub.catheter, by measuring the pressure in the patient line region P.sub.1 (e.g., near the patient line port) over time. The pressure in the patient line region over time P.sub.1(t) is affected differently by the fluidic resistance R.sub.f increase depending upon the location of such an increase. The placement of the fluid capacitive element 1810 between the patient line region and the catheter region makes it possible to make such a distinction, as shown in the analysis below.
[0249] A specified flow waveform Q.sub.1(t) is provided to the patient line 1830. In this example, the flow waveform Q.sub.1(t) is known and is periodic such that it may be represented by a full Fourier transform as shown in Equation 12:
[0250] Equation 11 can be solved by superposition assuming that the fluidic resistance R.sub.f and the fluidic capacitance C.sub.f values are constant. In some examples, if the fluidic resistance R.sub.f and the fluidic capacitance C.sub.f values are not constant but are repeatable functions of flow and volume, respectively, a different method may be used to determine the expected characteristics of the pressures P versus the flow waveform Q.sub.1(t), such as numerical or experimental analysis. The result of the superposition provides a prediction of the pressure measured at the cycler P.sub.1(t), as shown in Equation 13:
[0251] In Equation 13, the characteristic frequency of the circuit ω.sub.o is given by Equation 14:
[0252] Equation 13 expresses the pressure at the cycler P.sub.1(t) (e.g., the pressure in the patient line region of the conduit as measured by the pressure sensor 151A) as the sum of a time-averaged and a transient (e.g., fluctuating) component. The time-averaged component is a function of the total fluidic resistance R.sub.f of the conduit:
Hence, an equivalent increase in either the fluidic resistance of the patient line region R.sub.line or the fluidic resistance of the catheter region R.sub.catheter will affect
[0253] On the other hand, inspection of the transient component of the pressure P.sub.1(t) reveals a separation of the effects of the fluidic resistance of the patient line region R.sub.line versus the fluidic resistance of the catheter region R.sub.catheter. A change in the fluidic resistance of the catheter region R.sub.catheter affects the characteristic frequency ω.sub.o, while a change in the fluidic resistance of the patient line region R.sub.line does not. Conversely, a change in the fluidic resistance of the patient line region R.sub.line alone affects the transient component of the pressure P.sub.1(t) through the terms R.sub.lineA.sub.n and R.sub.lineB.sub.n. Thus, if the transient component of the pressure P.sub.1(t) is measured and compared to expected characteristics, the location of an increase in flow resistance may be determined.
[0254] Because the values of A.sub.n and B.sub.n depend upon the shape of Q.sub.1(t), and the latter is to be imposed by design of the pump head operational protocol, it is advantageous to determine which waveform(s) Q.sub.1(t) will most specifically and sensitively reveal the location of resistance increase. Laplace transform analysis and experimental data provide the recommendations to follow.
[0255] An ordinary differential equation (e.g., such as Equation 11) with constant coefficients and a periodic forcing function, including one of impulsive character, is a good candidate for solution by the method of Laplace transforms. The solution may proceed as follows according to Equations 15-25, and its result complements that obtained by Fourier analysis in the previous section:
where (s) and
(s) are the Laplace transforms of Q.sub.1(t) and V.sub.f,2(t), respectively. Thus,
where V.sub.f2(t) is found by performing the inverse Laplace transform of Equation 18:
where
the inverse Laplace transform of which is g(t)=e.sup.−ω.sup.
[0256] Proceeding to invert Equation 20 according to the linearity properties of the transform and the convolution rule,
V.sub.f,2=(t)=V.sub.f,2(0)g(t)+∫.sub.0.sup.tg(t−τ)Q.sub.1(τ)dτ (21)
V.sub.f,2(t)=V.sub.f,2(0)e.sup.−ω.sup.t+∫.sub.0.sup.te.sup.−ω.sup.
[0257] Equation 22 provides input for Equation 24, an equation for the measured pressure P.sub.1(t), derived according to the circuit equations:
[0258] Similarly to the Fourier result above but in a different mathematical form, Equation 24 demonstrates how the capacitive element creates a separation of the effects of a change in the fluidic resistance of the patient line region R.sub.line versus a change in the fluidic resistance of the catheter region R.sub.catheter.
[0259] Depending upon the form of the flow waveform Q.sub.1(t), the integral in Equation 22 may be evaluated either analytically or numerically. In some implementations, the flow may be programmed to simplify the expected pressure waveform and to isolate the measurement of response time. Because the flow waveform Q.sub.1(t) is to be imposed by programmed pump head motion in this example, it may be appropriate to investigate the most advantageous achievable flow waveform Q.sub.1(t) (e.g., a flow waveform Q.sub.1(t) that results in the greatest sensitivity and specificity). In some examples, a simplifying case of the flow waveform Q.sub.1(t) may be a quasi-square wave with a frequency that is much less than the nominal value of the characteristic frequency ω.sub.o. That is, if the flow waveform Q.sub.1(t) entails a single dispensing step, with flow abruptly stopped, a period may follow in which Equation 24 is approximated by Equation 25:
[0260] Equation 25 shows how the measured time response of the pressure P.sub.1 may be used to measure the characteristic frequency ω.sub.o. Once the characteristic frequency ω.sub.o is known, Equation 24 can be used to infer a change (e.g., or lack thereof) in the fluidic resistance of the catheter region R.sub.catheter. If the change in the fluidic resistance of the catheter region R.sub.catheter equals a combined increase in the fluidic resistance of the patient line region R.sub.line and the fluidic resistance of the catheter region R.sub.catheter detected by steady-state measurement, then the occlusion is likely positioned in the catheter region of the conduit (e.g., an occlusion of the catheter 1802). Conversely, if a combined increase in the fluidic resistance of the patient line region R.sub.line and the fluidic resistance of the catheter region R.sub.catheter has occurred without a change in the fluidic resistance of the catheter region R.sub.catheter, then the occlusion is likely positioned in the patient line region of the conduit (e.g., a pinch of the patient line 1830).
[0261] In some implementations, the volumetric flow rate Q may be imposed in other ways; that is, the flow waveform Q.sub.1(t) may take on other forms. For example, in some implementations, the flow waveform Q.sub.1(t) can include a steady-state introduction of fluid, a ramped introduction of fluid, a parabolic introduction of fluid, and/or a cyclical introduction of fluid.
[0262] While the detection methods described herein have sometimes been described as being implemented in a testing environment, similar techniques can be employed for detecting occlusions in the conduit when the patient line is attached to a patient receiving a dialysis treatment (e.g., as shown in
[0263] While the dialysis system has been largely described as being a peritoneal dialysis (PD) system, other medical treatment systems can employ the techniques described herein. Examples of other medical treatment systems include hemodialysis systems, hemofiltration systems, hemodiafiltration systems, apheresis systems, and cardiopulmonary bypass systems.
[0264] While a number of equations for determining various parameters have been described above, in some implementations, such equations are used to illustrate a theoretical basis for the systems and techniques described herein and associated measurements and/or calculations. In some implementations, one or more elements of an equation may be different than those shown above. In some implementations, one or more values may be determined by empirical evaluation. For example, as described above with respect to Equation 6, in practice the relationship between the fluidic capacitance C.sub.f and the distance x between the patient line port and the occlusion can be evaluated by empirical means.
[0265]
[0266] The memory 2020 stores information within the system 2000. In some implementations, the memory 2020 is a computer-readable medium. The memory 2020 can, for example, be a volatile memory unit or a non-volatile memory unit. In some implementations, the memory 2020 stores information for causing the pumps of the dialysis system to operate as described herein.
[0267] The storage device 2030 is capable of providing mass storage for the system 2000. In some implementations, the storage device 2030 is a non-transitory computer-readable medium. The storage device 2030 can include, for example, a hard disk device, an optical disk device, a solid-date drive, a flash drive, magnetic tape, or some other large capacity storage device. The storage device 2030 may alternatively be a cloud storage device, e.g., a logical storage device including multiple physical storage devices distributed on a network and accessed using a network.
[0268] The input/output device 2040 provides input/output operations for the system 2000. In some implementations, the input/output device 2040 includes one or more of network interface devices (e.g., an Ethernet card), a serial communication device (e.g., an RS-232 10 port), and/or a wireless interface device (e.g., an 802.11 card, a 3G wireless modem, or a 4G wireless modem). In some implementations, the input/output device 2040 may include short-range wireless transmission and receiving components, such as Wi-Fi, Bluetooth, and/or near field communication (NFC) components, among others. In some implementations, the input/output device includes driver devices configured to receive input data and send output data to other input/output devices, e.g., keyboard, printer and display devices (such as the touch screen display 118). In some implementations, mobile computing devices, mobile communication devices, and other devices are used.
[0269] In some implementations, the system 2000 is a microcontroller (e.g., the microcontroller 1536 of
[0270] Although an example processing system has been described in
[0271] The term “computer system” may encompass all apparatus, devices, and machines for processing data, including by way of example a programmable processor, a computer, or multiple processors or computers. A processing system can include, in addition to hardware, code that creates an execution environment for the computer program in question, e.g., code that constitutes processor firmware, a protocol stack, a database management system, an operating system, or a combination of one or more of them.
[0272] A computer program (also known as a program, software, software application, script, executable logic, or code) can be written in any form of programming language, including compiled or interpreted languages, or declarative or procedural languages, and it can be deployed in any form, including as a standalone program or as a module, component, subroutine, or other unit suitable for use in a computing environment. A computer program does not necessarily correspond to a file in a file system. A program can be stored in a portion of a file that holds other programs or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files that store one or more modules, sub programs, or portions of code). A computer program can be deployed to be executed on one computer or on multiple computers that are located at one site or distributed across multiple sites and interconnected by a communication network.
[0273] Computer readable media suitable for storing computer program instructions and data include all forms of non-volatile or volatile memory, media and memory devices, including by way of example semiconductor memory devices, e.g., EPROM, EEPROM, and flash memory devices; magnetic disks, e.g., internal hard disks or removable disks or magnetic tapes; magneto optical disks; and CD-ROM and DVD-ROM disks. The processor and the memory can be supplemented by, or incorporated in, special purpose logic circuitry. The components of the system can be interconnected by any form or medium of digital data communication, e.g., a communication network. Examples of communication networks include a local area network (“LAN”) and a wide area network (“WAN”), e.g., the Internet.
[0274] A number of implementations of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other implementations are within the scope of the following claims.